TipRanks
Corvus Pharmaceuticals Inc (DE:C17)
FRANKFURT:C17

Compare Corvus Pharmaceuticals (C17) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Corvus Pharmaceuticals
€12.24
€754.43M
-14.70
47.59%
4 Buy
0 Hold
0 Sell
Strong Buy
Xencor
$28.44
$1.86B
-10.84
68.48%
11 Buy
2 Hold
0 Sell
Strong Buy
CytomX Therapeutics
$3.37
$527.32M
-5.17
-31.62%
5 Buy
0 Hold
0 Sell
Strong Buy
Kura Oncology
$13.59
$924.75M
-2.92
-1.01%
11 Buy
0 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$13.83
$1.22B
-8.38
-18.69%
9 Buy
0 Hold
0 Sell
Strong Buy
Immatics
$9.43
$1.08B
-3.83
-32.31%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:C17
Corvus Pharmaceuticals
8.63
2.63
43.90%
XNCR
Xencor
23.52
11.09
89.22%
CTMX
CytomX Therapeutics
2.33
-1.09
-32.02%
KURA
Kura Oncology
9.83
0.21
2.18%
ORIC
Oric Pharmaceuticals
11.31
-1.85
-14.06%
IMTX
Immatics
6.83
-3.34
-32.84%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts